We are the Team + Capital to bring important medical technology to China.
China is a rapidly expanding market of importance to emerging healthcare companies around the world. However, few medical technology companies have the resources and staff to properly pursue opportunities in China.

Domain Elite invests strategic capital to commercialize important medical technologies in China. Our investment funds are invested into Chinese medical businesses and overseas medical products developers to unlock the potential of the China market.

Domain Elite is fully staffed in Beijing to conduct CFDA regulatory, medical/clinical, business development, and commercialization of medical technology in China. We bring the deep understanding of the China market, the capital, and the people to make it happen. Beyond our ability to incubate medical businesses in Beijing, we have working relationships with hundreds of domestic Chinese medical businesses and provide a bridge for managing Chinese partnerships.


Domain Elite is a joint venture of Domain Associates (Princeton, NJ and San Diego, CA) and Elite Consulting (Beijing).

Beijing Elite: Experts in establishing Chinese healthcare businesses and business units.

Domain Associates: Unmatched deal flow and deep networks into promising emerging companies.

About Domain Associates, founded in 1985, is one of the longest standing venture capital firms focused exclusively on the healthcare sector. Domain’s eight successive funds (‘86, ‘91, ‘94, ‘98, ‘01, ‘03, ‘06, ’09) have invested nearly $3 billion in innovative pharmaceuticals, diagnostics, and medical devices. Over 180 medical companies have been created by Domain Associates’ investment.

Based in Princeton, NJ and San Diego, CA, Domain are active investors who partner with entrepreneurs to help build great companies. Domain are experienced, trustworthy, leaders with a track record of novel investment models to drive returns.

About Elite Consulting, founded in 1997 by six Chinese executives from the pharmaceutical and diagnostics industry, Beijing Elite Management Consulting is located in Beijing and has an active client base of 1,200 domestic pharmaceutical and medical product companies in China. Elite Consulting has strong strategic and execution capabilities, and has extensive investment experience via advisory work and co-investment.

Elite Consulting provides sales and marketing management services, contract executive management, high-level SFDA experts and registration services, clinical development expertise, marketing research, and a partially owned sister company provides formulation, manufacturing, and cGMP consulting for international and domestic pharmaceutical and device manufacturers in China. Elite also is among the most active commercial due diligence providers in the China healthcare industry. Annually, Elite conducts diligence on more than $500 million of direct investment in the pharmaceutical, device, and hospital industries in China.


  • Premium Deal Flow: Due to Domain history, networks, and reputation
  • Advantaged Access to Competitive Deals: Due to Beijing Elite unique ability to unlock China market value
    and Domain’s proven ability to build companies of value in US market
  • Premium Exit Values: Due to ability to advance the Chinese business opportunity
    that lays dormant in many emerging companies today


We invest in medical device, in-vitro diagnostics, and pharmaceutical products that fit the needs of the Chinese market. Typically our investments involve products that have completed significant scale human clinical trials.

Domain Elite is an active investor in the China neurovascular, gastro-enterology, and in-vitro diagnostics industries in China.

Domain Elite works closely with Domain Associates’ companies to unlock the value of the Chinese market Domain and Elite maintain networks of thousands of executives and manufacturers in China and the United States.

Our respective infrastructures enable deep insight, and fast, dedicated commercialization teams to bring the China market potential to reality.


Domain Elite Invests in Smart Medical Systems, Ltd.:
Smart Medical Systems develops medical devices for balloon enhanced endoscopy which prevent colon cancer and perform faster and less expensive endoscopic procedures. The Chinese endoscopy market growing at 30 percent annually.

Although SMART recognized the value of pursuing China with Elite, a challenge in the deal was that SMART did not want to separate China and global rights. An structure was found to allow joint investment and provide an active role for DEH to drive market entry in China. Domain Elite invested in SMART Medical, with certain monies earmarked for China; to allow value to accrue to all shareholders as progress is made in Chinese market and/or global markets.

As part of the investment, DEH provided financing and management to create Medico Ltd, an exclusive distributor of Smart Medical’s products for Greater China. Domain Elite’s funds are being used to fund clinical, regulatory, manufacturing, and promotion of Smart Medical’s products in Greater China. Domain Elite is active in the board of directors of Medico and Smart Medical as well as Medico operations in China.

Elite Neurovascular / Sequent Medical:
Sequent Medical is the developer of innovative cerebrovascular aneurism embolization devices. China is the world’s second largest neurovascular market.

Domain Elite Holdings created Elite Neurovascular to fund and operate the clinical and regulatory development of Sequent Medical’s WEB products in Mainland China. Elite Neurovascular may also develop future commercial opportunities for Sequent in China and inlicense additional neurovascular products.

Contact Information

2U, Block A, Guomen Building, No. 1 Zuojiazhuang,

Chaoyang District, Beijing, China, 100028

+8610 84517085


elite_com BJ elite logo domain-associates-logo